RAndomised controlled trial to imProve depressIon and the quality of life of people with Dementia using cognitive bias modification: RAPID study protocol

INTRODUCTION: Depressive symptoms are common and undermine the quality of life of people with Alzheimer's disease (AD). Cholinesterase inhibitors and antidepressants have all but no effect on the mood of patients, and their use increases adverse events. Cognitive bias modification (CBM) targets...

Descripción completa

Detalles Bibliográficos
Autores principales: Almeida, Osvaldo P, MacLeod, Colin, Flicker, Leon, Ford, Andrew, Grafton, Ben, Etherton-Beer, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Mental Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4120303/
https://www.ncbi.nlm.nih.gov/pubmed/25056981
http://dx.doi.org/10.1136/bmjopen-2014-005623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4120303/
https://www.ncbi.nlm.nih.gov/pubmed/25056981
http://dx.doi.org/10.1136/bmjopen-2014-005623

Ejemplares similares